Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why I rate DERM stock a Buy.
Treasury yields from 7 to 30 years out trade at or above 3%, a day after Fed delivers half-point rate hike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback